New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2013
15:30 EDTSNX, XRTXCompanies reporting After the Market Close on Thursday, January 10
Notable companies reporting after the closing bell on Thursday include SYNNEX (SNX) and Xyratex (XRTX).
News For SNX;XRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 28, 2015
19:11 EDTSNXOn The Fly: After Hours Movers
HIGHER: Yahoo (YHOO), up 3.3% after the board authorized Yahoo to continue to pursue the Aabaco spin-off plan... Cheniere Energy (LNG), up 0.67% after Carl Icahn raised his stake in the company to 11.43%... Republic Airways (RJET), up 7.4% after the company was upgraded to Buy from Hold at Deutsche Bank... Exelon (EXC) and Pepco (POM), higher by 1% and 2.4%, respectively, after the DC Mayor's office released a statement confirming discussions of a settlement agreement with the companies. LOWER AFTER EARNINGS: SYNNEX (SNX), down 2.7% after the company reported Q3 results, gave Q4 guidance, and raised its quarterly dividend. ALSO LOWER: Zosano (ZSAN), down 52.5% after it discontinued development of its Daily ZP-PTH treatment for severe osteoporosis and terminated a collaboration agreement with Eli Lilly (LLY)... OvaScience (OVAS), down 15.9% after the company announced it doesn't expect to meet its previous 2015 goal of 1,000 Augment treatment cycles.
16:29 EDTSNXSYNNEX raises quarterly dividend to 20c from 12c per share
The dividend will be payable on October 30 to stockholders of record as of the close of business on October 16.
16:27 EDTSNXSYNNEX sees Q4 adjusted EPS $1.74-$1.79, consensus $1.78
Subscribe for More Information
16:26 EDTSNXSYNNEX reports Q3 adjusted EPS $1.47, consensus $1.43
Reports Q3 revenue $3.33B, consensus $3.38B.
15:00 EDTSNXNotable companies reporting after market close
Subscribe for More Information
September 25, 2015
07:08 EDTSNXSYNNEX price target raised to $97 from $90 at Brean Capital
Brean Capital raised its price target on SYNNEX to $97 from $90 to reflect its best in breed status. The firm cited expectations for both a revenue and OM benefit in Q2, its demand opportunity for products and its ability to continue with beat and raise quarters. Brean Capital reiterated its Buy rating on SYNNEX shares.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use